|
 |
Best Practice in Clinical Site Selection & Management |
|
|
22-25 April 2008
Hotel Princesa Sofia, Barcelona, Spain
How challenging is it to improve predictability when selecting clinical sites?
How often are there delays in site start-up that could have been avoided?
How difficult is it to maximise an individual site’s performance compared to the original feasibility study?
How important would it be for you to network with and share perspectives from all stakeholders involved in site performance: Pharma, CRO’s, SMO’s and representatives from individual clinical sites?
If these issues are important to you, then it would be beneficial for you and your colleagues to attend this unique conference looking specifically at best practice at the individual site level, the front-end of clinical operations.
Best Practice in Clinical Site Selection and Management
Maximising Individual Site Performance in a Saturated Market
At this timely conference and networking meeting you can:
• Hear fresh perspectives on improving the efficiency of clinical operations at the very front-end; understanding the relationships with sites and their crucial relationships with patients.
• Understand the perspectives of, not only senior clinical operations directors, but also clinical managers who manage the day to day relationships with the site. Also, crucially, views from CROs and the sites themselves; principal investigators and experienced study nurses.
• Participate in your choice of either hands-on or more technical pre-conference interactive workshops: metrics to improve clinical site performance, or innovative patient recruitment techniques from the perspective of respected clinical sites.
• Join relaxed, informal partnering sessions to meet unique and niche, clinical solution providers who can help you maximize your relationships with the clinical site and help speed up your clinical trials.
• Attend an exclusive and complimentary networking dinner between all key stakeholders. Stronger relationships will be built upon a better understanding of the challenges faced by each group, who are all vital to the success of a study.
A unique list of speakers from pharma, clinical sites and expert solution providers like:
Genzyme, Lundbeck, Pfizer, Celgene, Schering-Plough, Biogen-Idec, Mundipharma, BfArM (Germany), University of Tampere Medical School (Finland), Barts and the London NHS Trust (UK), Queen Mary University of London, Hospital Universitario de Bellvitge (Barcelona), Charles University (Prague), Norfolk and Norwich University Hospital, TFS - Trial Form Support, NMCT AB - Nordic Management Clinical Trials, Oracle, CMR International (Thomson Scientific).
If this is of interest to you, please contact me as soon as possible. The meeting is already proving to be very popular and the number of attendees is limited.
Best regards,
Andrea Valent
Marketing Manager
Phone: +421 2 3266 2621
Direct: +421 2 3266 0387
Fax: +421 2 3266 2622
E-mail: andrea@nextlevelpharma.com
|
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities… Learn
more
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
|
